Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 9/20 | 0.36 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.35 |
| ▸ | AURKA | O14965 | 2/20 | 0.33 |
| ▸ | ITK | Q08881 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | AGER | Q15109 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL856424 | 0.86 | ACHE (0.37) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL856160 | 0.84 | ACHE (0.35) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL856241 | 0.82 | ACHE (0.33) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL857297 | 0.82 | AURKA (0.34) | ACHEAURKAITKMAPK1LCK | |
| SCHEMBL3723441 | 0.73 | ACHE (0.35) | ACHEAGERTP53 | |
| SCHEMBL3717335 | 0.72 | AGER (0.34) | ACHEAGERTP53 | |
| SCHEMBL857343 | 0.72 | PTGDR2 (0.41) | ACHEAGER | |
| SCHEMBL857463 | 0.72 | AURKA (0.36) | ACHEAURKAITKMAPK1MAPT | |
| SCHEMBL858893 | 0.70 | TP53 (0.35) | ACHEAURKAITKMAPK1MAPT | |
| SCHEMBL858891 | 0.69 | TP53 (0.35) | ACHEAURKAITKMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432779-A1 | BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES | Exelixis, Inc. (US) | 2012-03-28 | — | — | EP | disclosed |